Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celsius Holdings, Inc.CELH · Entity 3658 | 10% owner | July 12, 2023 | July 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celsius Holdings, Inc.
Report date July 12, 2023 · Filed July 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CallsSEC Table II · derivative / convertible security · Conversion / exercise price $210.00 | IndirectSee footnote | 0 |
Reported balance
After 2023-07-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-07-12 · Sale · Disposed 500,000 · Balance 0 F1: Calls represent the right of the option holder to buy, and the obligation of the option seller to sell, the shares subject to the options at the strike price. F3: On July 12 2023, CD entered into a call option transaction with an unaffiliated third-party purchaser. Pursuant to the terms of the option transaction, CD sold 500,000 call options referencing 500,000 shares of Celsius Holdings, Inc. ("Celsius") (with expiration and exercise occurring in ten approximately equal components from January 21, 2025 to February 3, 2025). In exchange, CD will receive a cash payment of option premium of $21.41 per option on July 14, 2023. F4: CD pledged 500,000 shares of Celsius common stock (the "Pledged Shares") to secure its obligations under the contract and retained dividend and voting rights in the Pledged Shares during the term of the pledge. F5: The contract provides that the number of shares of Celsius common stock that CD would be obligated to sell to the purchaser in respect of each maturity date would be determined as follows: (a) if the volume-weighted average price of Celsius common stock on the designated valuation date for the applicable component (each, a "Valuation Price") is less than or equal to the strike price of the options, the options will expire worthless and no shares will be sold; (b) if such Valuation Price is greater than the strike price, the relevant options will be automatically exercised, CD will either (x) deliver to the buyer the number of shares subject to the applicable component in exchange for payment of a purchase price per share equal to the strike price or (y) pay in cash an amount per share equal to the excess of such Valuation Price over the strike price. F2: Carl DeSantis owns a beneficial interest of 100% in CD Financial, LLC ("CD"). |
Filing footnotes · ownership attribution and instrument terms
F1: Calls represent the right of the option holder to buy, and the obligation of the option seller to sell, the shares subject to the options at the strike price.
F2: Carl DeSantis owns a beneficial interest of 100% in CD Financial, LLC ("CD").
F3: On July 12 2023, CD entered into a call option transaction with an unaffiliated third-party purchaser. Pursuant to the terms of the option transaction, CD sold 500,000 call options referencing 500,000 shares of Celsius Holdings, Inc. ("Celsius") (with expiration and exercise occurring in ten approximately equal components from January 21, 2025 to February 3, 2025). In exchange, CD will receive a cash payment of option premium of $21.41 per option on July 14, 2023.
F4: CD pledged 500,000 shares of Celsius common stock (the "Pledged Shares") to secure its obligations under the contract and retained dividend and voting rights in the Pledged Shares during the term of the pledge.
F5: The contract provides that the number of shares of Celsius common stock that CD would be obligated to sell to the purchaser in respect of each maturity date would be determined as follows: (a) if the volume-weighted average price of Celsius common stock on the designated valuation date for the applicable component (each, a "Valuation Price") is less than or equal to the strike price of the options, the options will expire worthless and no shares will be sold; (b) if such Valuation Price is greater than the strike price, the relevant options will be automatically exercised, CD will either (x) deliver to the buyer the number of shares subject to the applicable component in exchange for payment of a purchase price per share equal to the strike price or (y) pay in cash an amount per share equal to the excess of such Valuation Price over the strike price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTEGRATED BIOPHARMA INC
Report date April 15, 2026 · Filed April 17, 2026
Section 16 reporting ended · disclosed 2026-04-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectReporting Person is deceased | 2,235,417 |
Reported balance
After 2026-04-15 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-04-15 · Gift · Disposed 8,966,547 · Balance 2,235,417 F1: Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis. |
| Common StockSEC Table I · non-derivative | IndirectReporting Person is deceased | 0 |
Reported balance
After 2026-04-15 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-04-15 · Gift · Disposed 2,235,417 · Balance 0 F2: Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.
F2: Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2020 Filed Feb 11, 2021 17:12 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-008359 · doc4.xml · nonDerivative · entry 2 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: 870,000 F1 · shares: Represents a transfer from the Carl DeSantis Revocable Trust to the Carl Angus DeSantis Foundation. Read SEC document |
| December 31, 2020 Filed Feb 26, 2021 19:12 UTC Amendment | Celsius Holdings, Inc. CELH · Entity 3658 | GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-012016 · doc4.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Carl Angus DeSantis Foundation Disclosed balance after: 30,000 F1 · balance_after: This amendment is being filed to reflect the number of shares held by the Carl Angus DeSantis Foundation in which the reporting person has no pecuniary interest. Mr. DeSantis serves as a Director of the Foundation. Read SEC document |
| December 21, 2020 Filed Feb 11, 2021 17:12 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-008359 · doc4.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: 900,000 Read SEC document |
| November 25, 2020 Filed Nov 27, 2020 16:19 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock | 159,054 | $30.71 | $4,884,548.34 |
DisclosureSEC source: 0001213900-20-039506 · doc4.xml · nonDerivative · entry 2 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 22,209,152 F1 · shares: The shares were held and sold by CD Financial, LLC. Carl DeSantis is the beneficial owner of 100% of CD Financial, LLC. F2 · ownership.nature: CD Financial, LLC and CDS Ventures of South Florida, LLC are the holders of the shares of common stock. Carl DeSantis owns a beneficial interest of 100% in both entities. Read SEC document |
| November 25, 2020 Filed Feb 11, 2021 17:08 UTC Amendment | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock | 159,054 | $30.71 | $4,884,548.34 |
DisclosureSEC source: 0001213900-21-008357 · doc4.xml · nonDerivative · entry 2 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By CD Financial, LLC Disclosed balance after: 6,848,841 F1 · shares: The shares were held and sold by CD Financial, LLC. Carl DeSantis is the beneficial owner of 100% of CD Financial, LLC. F2 · balance_after: This amendment is being filed to reflect the number of shares held by CD Financial, LLC and entities below following the transaction. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 16:19 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock | 300,000 | $31.89 | $9,567,000.00 |
DisclosureSEC source: 0001213900-20-039506 · doc4.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 22,368,206 F1 · shares: The shares were held and sold by CD Financial, LLC. Carl DeSantis is the beneficial owner of 100% of CD Financial, LLC. F2 · ownership.nature: CD Financial, LLC and CDS Ventures of South Florida, LLC are the holders of the shares of common stock. Carl DeSantis owns a beneficial interest of 100% in both entities. Read SEC document |
| November 24, 2020 Filed Feb 11, 2021 17:08 UTC Amendment | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock | 300,000 | $31.89 | $9,567,000.00 |
DisclosureSEC source: 0001213900-21-008357 · doc4.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By CD Financial, LLC Disclosed balance after: 7,007,895 F1 · shares: The shares were held and sold by CD Financial, LLC. Carl DeSantis is the beneficial owner of 100% of CD Financial, LLC. F2 · balance_after: This amendment is being filed to reflect the number of shares held by CD Financial, LLC and entities below following the transaction. Read SEC document |
| November 04, 2020 Filed Nov 20, 2020 22:18 UTC | INTEGRATED BIOPHARMA INC inbp · Entity 8227 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001345281-20-000008 · primary_doc.xml · derivative · entry 1 DESANTIS CARL · CIK 0001102948 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-11-04 F1 · derivative.exercise_date: The option vests and becomes exercisable as follows: 42% (20,831 shares) on November 19, 2020 and in seven equal monthly installments for the remaining 58% (29,169 shares) beginning on December 1, 2020. Read SEC document |
| August 25, 2020 Filed Aug 31, 2020 21:12 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock | 720,784 | $15.30 | $11,027,995.20 |
DisclosureSEC source: 0001213900-20-024624 · doc4.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 22,668,206 F1 · ownership.nature: CD Financial, LLC and CDS Ventures of South Florida, LLC are the holders of the shares of common stock. Carl DeSantis owns a beneficial interest of 100% in both entities. Read SEC document |
| August 25, 2020 Filed Feb 11, 2021 17:07 UTC Amendment | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock | 720,784 | $15.30 | $11,027,995.20 |
DisclosureSEC source: 0001213900-21-008354 · doc4.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By CD Financial, LLC Disclosed balance after: 7,307,895 F1 · shares: The shares were sold by CD Financial, LLC. Carl DeSantis owns a beneficial interest of 100% in CD Financial, LLC. F2 · balance_after: This amendment is being filed to reflect the number of shares held by CD Financial, LLC and entities below following the transaction. Read SEC document |
| June 11, 2020 Filed Feb 11, 2021 17:04 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | OtherCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-008352 · doc4.xml · nonDerivative · entry 2 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: 1,000,000 F1 · shares: Represents a loan of shares from CD Financial, LLC to Carl DeSantis and subsequent transfer of such shares to the Carl DeSantis Revocable Trust. The reporting person is the trustee of the trust. Read SEC document |
| June 11, 2020 Filed Feb 11, 2021 17:04 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | OtherCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-008352 · doc4.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By CD Financial, LLC Disclosed balance after: 8,028,679 F1 · shares: Represents a loan of shares from CD Financial, LLC to Carl DeSantis and subsequent transfer of such shares to the Carl DeSantis Revocable Trust. The reporting person is the trustee of the trust. Read SEC document |
| September 12, 2019 Filed Sep 12, 2019 20:23 UTC Amendment | Celsius Holdings, Inc. CELH · Entity 3658 | ConversionConvertible Note · Derivative | 1,492,385 | $5,000,000.00 Strike: $3.39 | $7,461,925,000,000.00 |
DisclosureSEC source: 0001102948-19-000003 · primary_doc.xml · derivative · entry 3 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Holder of convertible note was CD Financial, LLC Disclosed balance after: 0 Underlying: Common Stock · 1,492,385 shares Expires 2020-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2019 Filed Sep 12, 2019 20:23 UTC Amendment | Celsius Holdings, Inc. CELH · Entity 3658 | ConversionCommon Stock | 1,492,385 | $3.39 | $5,059,185.15 |
DisclosureSEC source: 0001102948-19-000003 · primary_doc.xml · nonDerivative · entry 2 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 23,333,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents the conversion of the outstanding principal and interest under that certain convertible promissory note previously issued to CD Financial, LLC on December 14, 2018. F1 · ownership.nature: CD Financial, LLC and CDS Ventures of South Florida, LLC are the holders of the shares of common stock. Carl DeSantis owns a beneficial interest of 100% in both entities. Read SEC document |
| September 12, 2019 Filed Sep 12, 2019 20:23 UTC Amendment | Celsius Holdings, Inc. CELH · Entity 3658 | PurchaseCommon Stock | 500,000 | $3.60 | $1,800,000.00 |
DisclosureSEC source: 0001102948-19-000003 · primary_doc.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 21,841,295 F1 · ownership.nature: CD Financial, LLC and CDS Ventures of South Florida, LLC are the holders of the shares of common stock. Carl DeSantis owns a beneficial interest of 100% in both entities. Read SEC document |
| September 12, 2019 Filed Sep 12, 2019 19:51 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | ConversionConvertible Note · Derivative | 1,492,385 | $5,000,000.00 Strike: $3.39 | $7,461,925,000,000.00 |
DisclosureSEC source: 0001102948-19-000002 · primary_doc.xml · derivative · entry 2 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Holder of convertible note was CD Financial, LLC Disclosed balance after: 0 Underlying: Common Stock · 1,492,385 shares Expires 2020-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2019 Filed Sep 12, 2019 19:51 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | ConversionCommon Stock | 1,492,385 | $3.39 | $5,059,185.15 |
DisclosureSEC source: 0001102948-19-000002 · primary_doc.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 22,833,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion of the outstanding principal and interest under that certain convertible promissory note previously issued to CD Financial, LLC on December 14, 2018. F2 · ownership.nature: CD Financial, LLC and CDS Ventures of South Florida, LLC are the holders of the shares of common stock. Carl DeSantis owns a beneficial interest of 100% in both entities. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 18:34 UTC Amendment | Celsius Holdings, Inc. CELH · Entity 3658 | ConversionCommon Stock | 1,492,385 | $3.39 | $5,059,185.15 |
DisclosureSEC source: 0001102948-19-000004 · primary_doc.xml · nonDerivative · entry 2 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 23,389,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents the conversion of the outstanding principal and interest under that certain convertible promissory note previously issued to CD Financial, LLC on December 14, 2018. F1 · balance_after: The number of shares of common stock is being amended to reflect an increased amount acquired of 555,555 shares. F2 · ownership.nature: CD Financial, LLC and CDS Ventures of South Florida, LLC are the holders of the shares of common stock. Carl DeSantis owns a beneficial interest of 100% in both entities. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 18:34 UTC Amendment | Celsius Holdings, Inc. CELH · Entity 3658 | PurchaseCommon Stock | 555,555 | $3.60 | $1,999,998.00 |
DisclosureSEC source: 0001102948-19-000004 · primary_doc.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 21,896,850 F1 · shares: The number of shares of common stock is being amended to reflect an increased amount acquired of 555,555 shares. F1 · balance_after: The number of shares of common stock is being amended to reflect an increased amount acquired of 555,555 shares. F2 · ownership.nature: CD Financial, LLC and CDS Ventures of South Florida, LLC are the holders of the shares of common stock. Carl DeSantis owns a beneficial interest of 100% in both entities. Read SEC document |
| May 24, 2019 Filed May 29, 2019 21:17 UTC | INTEGRATED BIOPHARMA INC inbp.ob · Entity 8227 | GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001102948-19-000001 · primary_doc.xml · derivative · entry 1 DESANTIS CARL · CIK 0001102948 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2029-05-24 F1 · derivative.exercise_date: The option vests 67% (100,000) on grant date (May 24, 2019) and in twelve equal monthly installments for the remaining 33% (50,000) beginning on July 1, 2019. Read SEC document |
| December 14, 2018 Filed Dec 19, 2018 22:23 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | PurchaseConvertible Note · Derivative | Not disclosed | $5,000,000.00 Strike: $3.40 | $5,000,000.00 |
DisclosureSEC source: 0001102948-18-000003 · primary_doc.xml · derivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: Not disclosed Underlying: Common Stock · 1,470,588 shares Expires not disclosed F1 · security: The Note bears interest at a rate of 5% per annum. F2 · derivative.expiration_date: The Note is convertible, at the election of its holder CD Financial, LLC, on or prior to the maturity date of 12/14/2020. F3 · ownership.nature: CD Financial, LLC is the holder and lender pursuant to the Note. Carl DeSantis owns a beneficial interest of 100% in CD Financial, LLC. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 23:13 UTC | INTEGRATED BIOPHARMA INC INBP.OB · Entity 8227 | OtherCommon Stock | 8,230,769 | $0.65 | $5,349,999.85 |
DisclosureSEC source: 0001443197-18-000002 · primary_doc.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,409 F1 · price: Common stock issued to CD Financial, LLC as the result of CD Financial, LLC exercising the conversion right under the amended and restated convertible subordinated debt of $5.3 million held by CD Financial, LLC of which the Reporting Person is a member. F2 · balance_after: Includes 100,000 shares of common stock issuable upon exercise of presently exercisable stock options. Read SEC document |
| July 24, 2018 Filed Aug 1, 2018 23:13 UTC | INTEGRATED BIOPHARMA INC INBP.OB · Entity 8227 | Conversion6% secured convertible note due 2020, as amended · Derivative | Not disclosed | $5,350,000.00 Strike: $0.65 | $5,350,000.00 |
DisclosureSEC source: 0001443197-18-000002 · primary_doc.xml · derivative · entry 3 DESANTIS CARL · CIK 0001102948 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · 1 Disclosed balance after: 0 Underlying: Common Stock · 8,230,769 shares Expires 2020-02-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · reported_value: Common stock issued to CD Financial, LLC as the result of CD Financial, LLC exercising the conversion right under the amended and restated convertible subordinated debt of $5.3 million held by CD Financial, LLC of which the Reporting Person is a member. F4 · reported_value: On July 31, 2018, the Issuer issued 8,230,769 shares upon the receipt of a conversion notice from CD Financial, LLC settling the 6% secured convertible note in full. F1 · price: Common stock issued to CD Financial, LLC as the result of CD Financial, LLC exercising the conversion right under the amended and restated convertible subordinated debt of $5.3 million held by CD Financial, LLC of which the Reporting Person is a member. F4 · price: On July 31, 2018, the Issuer issued 8,230,769 shares upon the receipt of a conversion notice from CD Financial, LLC settling the 6% secured convertible note in full. F1 · ownership.nature: Common stock issued to CD Financial, LLC as the result of CD Financial, LLC exercising the conversion right under the amended and restated convertible subordinated debt of $5.3 million held by CD Financial, LLC of which the Reporting Person is a member. F4 · ownership.nature: On July 31, 2018, the Issuer issued 8,230,769 shares upon the receipt of a conversion notice from CD Financial, LLC settling the 6% secured convertible note in full. Read SEC document |
| March 28, 2018 Filed Jun 27, 2018 19:45 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | ConversionSeries D Convertible Preferred Stock · Derivative | 4,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001102948-18-000002 · primary_doc.xml · derivative · entry 2 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 4,651,163 shares Expires 2020-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The holder of Series D Convertible Preferred Shares has the right to convert at any time until the applicable expiration date for such shares. F3 · balance_after: CD Financial, LLC does not hold any shares of Series D Convertible Preferred Stock after the March 28, 2018 conversion. F3 · ownership.nature: CD Financial, LLC does not hold any shares of Series D Convertible Preferred Stock after the March 28, 2018 conversion. Read SEC document |
| March 28, 2018 Filed Jun 27, 2018 19:45 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | ConversionCommon Stock | 4,651,163 | $0.86 | $4,000,000.18 |
DisclosureSEC source: 0001102948-18-000002 · primary_doc.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,535,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Carl DeSantis owns a beneficial interest of 100% in CD Financial, LLC which is the holder of record of the 4,651,163 shares of common stock. Represents shares of common stock received by CD Financial, LLC upon conversion of shares of Series D Convertible Preferred Stock. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 20:08 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | OtherSeries C Convertible Preferred Stock · Derivative | 383 | $1,000.00 Strike: $0.52 | $383,000.00 |
DisclosureSEC source: 0001102948-17-000003 · primary_doc.xml · derivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · CDS Ventures of South Florida, LLC Disclosed balance after: 2,763 Underlying: Common Stock · 736,538 shares Expires 2018-12-31 F1 · kind: Represents the issuance to CDS Ventures of South Florida, LLC, as the holder of shares of Series C Convertible Preferred Stock, of 383 additional shares of Series C Convertible Preferred Stock pursuant to the applicable preferred dividend that accrues on the stated value of such shares at a rate of 6% per annum. F2 · derivative.exercise_date: The holder of Series C Convertible Preferred Stock has the right to convert at any time until the applicable maturity date for such shares. F3 · ownership.nature: Carl DeSantis owns a beneficial interest of 100% in CDS Ventures of South Florida, LLC which is the holder of record of the shares of Series C Convertible Preferred Stock listed above. Read SEC document |
| January 31, 2017 Filed Feb 10, 2017 23:29 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | PurchaseCommon Stock | 333,333 | $3.00 | $999,999.00 |
DisclosureSEC source: 0001102948-17-000002 · primary_doc.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,884,070 F1 · ownership.nature: Carl DeSantis owns a beneficial interest of 100% in CD Financial, LLC and CDS Ventures of South Florida, LLC, which are the holders of record of the shares of common stock. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 22:34 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | PurchaseCommon Stock | 100,000 | $3.00 | $300,000.00 |
DisclosureSEC source: 0001102948-17-000001 · primary_doc.xml · nonDerivative · entry 1 DESANTIS CARL · CIK 0001102948 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,550,737 F1 · ownership.nature: Carl DeSantis owns a beneficial interest of 100% in CD Financial, LLC and CDS Ventures of South Florida, LLC, which are the holders of record of the shares of common stock. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 21:28 UTC | INTEGRATED BIOPHARMA INC inpb.ob · Entity 8227 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001102948-16-000003 · primary_doc.xml · derivative · entry 1 DESANTIS CARL · CIK 0001102948 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-11-18 F1 · derivative.exercise_date: The option vests 5/12ths (20,831) on grant date (November 18, 2016) and in 7 monthly installments for the remaining 7/12ths (29,169) beginning on December 1, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.